Navigation Links
Genoptix Announces Participation at the 29th Annual William Blair Growth Stock Conference
Date:6/2/2009

CARLSBAD, Calif., June 2 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced the Company's participation at the 29th Annual William Blair Growth Stock Conference at The Four Seasons Hotel in Chicago, Ill. on June 9 - 11, 2009.

Genoptix's President and CEO, Dr. Tina Nova, and Sam Riccitelli, EVP and COO, will present at the conference on Wednesday, June 10, 2009 beginning at approximately 9:20 a.m. CDT. They will provide an overview of the Company's specialized diagnostic laboratory services business, growth strategies and financial performance.

The presentation is expected to last approximately 30 minutes, which will be web cast live and made accessible through the "Investors" section of the Genoptix website at www.genoptix.com. The presentation will be followed by a 30-minute audience Q&A session. Those who would like to listen to the presentation should go to this site at least 15 minutes prior to the event to register, download and install any necessary software. A replay will also be available for 30 days following the initial presentation web cast.

About Genoptix, Inc.

Genoptix is a leading specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to its physician customers, community-based hematologists and oncologists. On the forefront of personalized diagnostic services, Genoptix's highly trained group of hematopathologists utilize sophisticated technology to provide integrated testing and actionable diagnostic reports. Its diagnostic services are designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma. Founded in 1999, Genoptix completed its initial public offering in November 2007 and is headquartered in Carlsbad, California. For more information, please visit www.genoptix.com.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. Genoptix disclaims, however, any intent or obligation to update these forward-looking statements.


'/>"/>
SOURCE Genoptix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genoptix Announces Participation at the Bank of America and Merrill Lynch 2009 Annual Health Care Conference
2. Genoptix Reports Strong Growth for the First Quarter of 2009
3. Genoptix, Inc. to Announce First Quarter 2009 Financial Results
4. Genoptix Announces Participation at the Cowen and Company 29th Annual Health Care Conference
5. Genoptix Announces Participation at Barclays Capital Global Healthcare Conference
6. Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009
7. Genoptix Announces Participation at the RBC Capital Markets 2008 Healthcare Conference
8. Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008
9. Genoptix Announces the Addition of New Members to Board of Directors
10. Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008
11. Genoptix Reports Strong Financial Results for First Quarter 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Atlanta, Georgia (PRWEB) , ... January 19, 2017 ... ... Reconstructive Surgeons hosts the Atlanta Breast Surgery Symposium, a conference where hundreds of ... latest advancements in breast surgery. Covering topics from cosmetic breast augmentation ...
(Date:1/18/2017)... , ... January 18, 2017 , ... A recent video ... a global discussion about the benefits of fidgeting to relieve stress and anxiety. ... Daniel. Their Think Ink Pen had just completed a successful Kickstarter campaign raising ...
(Date:1/18/2017)... LAUDERDALE, FL (PRWEB) , ... January 18, 2017 ... ... how to manage it from the number one doctor-recommended OTC antiperspirant, Certain Dri. ... and often go untreated. , Certain Dri created this infographic to explain the ...
(Date:1/18/2017)... NJ (PRWEB) , ... January ... ... the specialty pharmacy industry’s leading journal and most-read publication among specialty pharmacists ... University Medical Center through its Strategic Alliance Partnership (SAP) program, announced Brian ...
(Date:1/18/2017)... ... 18, 2017 , ... PrideStaff, a national, franchised staffing ... Paula Turner Pizarro, was recently featured on Fox Business Network's Worldwide Business with ... business leaders from across the globe, provides viewers an opportunity to find solutions ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 18, 2017 The drug ... billion by 2021 from USD 1,179.20 billion in 2016, ... Increasing prevalence of chronic diseases, increasing demand for ... factors driving the growth of this market. Whereas, self-administration ... generic drugs offer significant growth opportunities for players operating ...
(Date:1/18/2017)... PUNE, India , January 18, 2017 /PRNewswire/ ... Research, titled, "Breast Imaging Technologies Market by Type: Global Opportunity ... imaging technologies market size was valued at $2,544 million in ... growing at a CAGR of 8.4% from 2016 to 2022. ... together accounted for over three-fourths market share in ...
(Date:1/18/2017)... Jan. 18, 2017   Regenicin, Inc. (OTC ... specializing in the development and commercialization of regenerative cell ... organs, recently reported the Company,s operating results for 2016 ... As the Company described in its recent 10-K ... of substantial accomplishments. The Company,s contract laboratory completed its ...
Breaking Medicine Technology: